Search company, investor...

Predict your next investment

Philips company logo
Corporation
CONSUMER PRODUCTS & SERVICES | Consumer Electronics
philips.com

Investments

56

Portfolio Exits

34

Partners & Customers

10

Service Providers

2

About Philips

Philips (AMS: PHIA) operates as a diversified technology company. It focuses on the areas of healthcare, consumer lifestyle, and lighting. It manufactures and sells a variety of products such as diagnostic imaging systems, image-guided therapy systems, trimmers and shavers, steam irons, car lights, toothbrushes, and more. It was founded in 1891 and is based in Amsterdam, Netherlands.

Headquarters Location

Amstelplein 2

Amsterdam, 1096 BC,

Netherlands

+31 20 597 7777

Want to inform investors similar to Philips about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Philips

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Philips in 1 Expert Collection, including Conference Exhibitors.

C

Conference Exhibitors

6,062 items

Companies that will be exhibiting at CES 2018

Latest Philips News

Thrombectomy Devices Market worth $2.1 Billion by 2027 - Exclusive Report by The Insight Partners

Sep 20, 2023

Global Thrombectomy Devices Market: Competitive Landscape and Key Developments Penumbra, Inc., Stryker Corporation, Medtronic, Inc.; Edward Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V, Teleflex Incorporated, Johnson & Johnson Services, Inc., Inari Medical, and Argon Medical among others are among the leading companies operating in the thrombectomy devices market. These players are focusing  on expanding and diversifying their market presence and acquiring a novel customer base, thereby tapping prevailing business opportunities in the thrombectomy devices market. These three players dominate the global thrombectomy devices market. These companies focus on various growth strategies such as collaboration, product launches, business expansions, agreements among others to retain its position in the global market. Many market players are launching their innovative products in the thrombectomy devices market with advanced features. For instance, In February 2022, Cernuous, part of Johnson & Johnson Medical Devices Companies, launched EMBOGUARD, a next-generation balloon guide catheter that is to be used in endovascular procedures, which also includes the patients with acute ischemic stroke. In November 2021, Penumbra Inc., announced that the CHEETAH, a clinical study of its Indigo System CA RX Catheter had successfully met the primary endpoint and demonstrated high rates of blood clot removal, blood flow restoration, and myocardial perfusion in conjunction with percutaneous coronary intervention (PCI) in patients with high thrombus burden. Increasing Research and Studies in Field of Thrombectomy are Creating Development Opportunities for Global Thrombectomy Devices Market Growth During 2019-2027: There is continuous research going on in the field of thrombectomy, related to various diseases to check the success rate. Recently, in May 2019, American Heart Association (AHA) / American Sociological Association (ASA) Journals published a report on the time and relevance of clinical improvement after mechanical thrombectomy in patients with acute ischemic stroke. This study concluded that the shorter delay to clinical improvement was related to better chances of a good long-term outcome, and an improvement was >30% in National Institutes of Health Stroke Scale score at the end of mechanical thrombectomy (MT). This study represents a reliable prognostic marker for clinicians and also for clinical research. Additionally, in June 2019, American Heart Association (AHA) / American Sociological Association (ASA) Journals also published a study on the recent nationwide impact of mechanical thrombectomy on decompressive hemicraniectomy for acute ischemic stroke. This study analyzed the impact of changes in stroke management on the nationwide trends in patient characteristics, treatment modalities, and outcomes. This study showed that successful reperfusion of penumbra with mechanical thrombectomy (MT) in stroke patients leads to declining indication for decompressive hemicraniectomy (DHC) while stroke volume increases with time. Therefore, increasing research studies related to thrombectomy is increasing the market of thrombectomy devices. Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPHE100001313 Global Thrombectomy Devices Market: Segmental Overview The “Global Thrombectomy Devices Market” is segmented based on type, application, end user, and geography. Based on type, the thrombectomy devices market is segmented into mechanical thrombectomy devices, rheolytic thrombectomy devices, aspiration thrombectomy devices, and ultrasonic thrombectomy devices. In 2018, the mechanical thrombectomy devices segment held the largest share of the market. However, mechanical thrombectomy devices segment is expected to register the highest CAGR of 6.4% in the market during the forecast period Based on application, the thrombectomy devices market is segmented into neurovascular, peripheral vascular, cardiovascular and others. In 2018, cardiovascular segment held the largest share of the market. However, peripheral vascular segment is expected to grow at the fastest rate during the coming year. Based on end user, the thrombectomy devices market is segmented into hospitals & clinics, ambulatory surgical centers, and academic & research institutes. In 2018, hospitals segment held the largest share of the market. However, the hospitals segment is expected to grow at the fastest rate during the coming year. Go through further research published by The Insight Partners:

Philips Investments

56 Investments

Philips has made 56 investments. Their latest investment was in PVmed as part of their Series A - IV on December 12, 2022.

CBI Logo

Philips Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/23/2022

Series A - IV

PVmed

$14M

No

4

5/13/2022

Corporate Minority - P2P - II

B-SOFT

$180M

Yes

1

2/23/2022

Series A

CVAid Medical

$4M

Yes

5

8/24/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

8/20/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/23/2022

5/13/2022

2/23/2022

8/24/2021

8/20/2021

Round

Series A - IV

Corporate Minority - P2P - II

Series A

Series B

Series A - II

Company

PVmed

B-SOFT

CVAid Medical

Subscribe to see more

Subscribe to see more

Amount

$14M

$180M

$4M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

1

5

10

10

Philips Portfolio Exits

34 Portfolio Exits

Philips has 34 portfolio exits. Their latest portfolio exit was ALung Technologies on May 05, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/5/2022

Acquired

$99M

2

3/21/2022

Spinoff / Spinout

InnoSIGN

$99M

2

9/30/2021

Reverse Merger

Shapeways

$99M

4

7/6/2021

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

5/5/2021

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/5/2022

3/21/2022

9/30/2021

7/6/2021

5/5/2021

Exit

Acquired

Spinoff / Spinout

Reverse Merger

Divestiture

Divestiture

Companies

InnoSIGN
Shapeways

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

2

4

10

10

Philips Acquisitions

45 Acquisitions

Philips acquired 45 companies. Their latest acquisition was DiA Imaging Analysis on May 08, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/8/2023

Series B

$99M

$19M

Acquired

2

12/14/2021

Series B

$99M

$52.46M

Acquired

5

11/8/2021

Series A

$99M

$21.4M

Acquired

4

1/19/2021

Growth Equity

Subscribe to see more

$99M

Subscribe to see more

10

12/18/2020

Other Venture Capital

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

5/8/2023

12/14/2021

11/8/2021

1/19/2021

12/18/2020

Investment Stage

Series B

Series B

Series A

Growth Equity

Other Venture Capital

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$19M

$52.46M

$21.4M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

2

5

4

10

10

Philips Partners & Customers

10 Partners and customers

Philips has 10 strategic partners and customers. Philips recently partnered with CoxHealth on July 7, 2023.

Date

Type

Business Partner

Country

News Snippet

Sources

7/27/2023

Client

United States

CoxHealth partners with Philips for in-house virtual care solution

Both Philips and CoxHealth jointly created a solution based on the close integration of Philips ' eCareManager enterprise telehealth software and Capsule Surveillance software .

3

7/19/2023

Partner

Switzerland

Philips Foundation partners with World Heart Federation to provide half a million children at risk of rheumatic heart disease with access to life-saving early detection

`` Our partnership with the World Heart Federation aims to drive improved early detection and treatment of rheumatic heart disease , while demonstrating the sustainability and cost-effectiveness of this innovative approach in the Philippines , '' said Margot Cooijmans , Director of the Philips Foundation .

3

6/22/2023

Licensor

Germany

Philips and BIOTRONIK Expand Care for Out-of-hospital Cardiology Labs with New Strategic Alliance

`` Philips is committed to expanding access to care through its innovative solutions and BIOTRONIK 's alliance adds additional devices , including a cardiac rhythm management portfolio , to SymphonySuite , '' said Chris DeCarolis , Head of Procedural Solutions for Image Guided Therapy at Philips .

2

6/7/2023

Client

United States

Subscribe to see more

Subscribe to see more

10

6/2/2023

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

7/27/2023

7/19/2023

6/22/2023

6/7/2023

6/2/2023

Type

Client

Partner

Licensor

Client

Partner

Business Partner

Country

United States

Switzerland

Germany

United States

United States

News Snippet

CoxHealth partners with Philips for in-house virtual care solution

Both Philips and CoxHealth jointly created a solution based on the close integration of Philips ' eCareManager enterprise telehealth software and Capsule Surveillance software .

Philips Foundation partners with World Heart Federation to provide half a million children at risk of rheumatic heart disease with access to life-saving early detection

`` Our partnership with the World Heart Federation aims to drive improved early detection and treatment of rheumatic heart disease , while demonstrating the sustainability and cost-effectiveness of this innovative approach in the Philippines , '' said Margot Cooijmans , Director of the Philips Foundation .

Philips and BIOTRONIK Expand Care for Out-of-hospital Cardiology Labs with New Strategic Alliance

`` Philips is committed to expanding access to care through its innovative solutions and BIOTRONIK 's alliance adds additional devices , including a cardiac rhythm management portfolio , to SymphonySuite , '' said Chris DeCarolis , Head of Procedural Solutions for Image Guided Therapy at Philips .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

3

2

10

10

Philips Service Providers

2 Service Providers

Philips has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

XMS Capital Partners

Acquired Unit

Investment Bank

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

XMS Capital Partners

Subscribe to see more

Associated Rounds

Acquired Unit

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Partnership data by VentureSource

Philips Team

193 Team Members

Philips has 193 team members, including current Chief Executive Officer, Neil Mesher.

Name

Work History

Title

Status

Neil Mesher

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Neil Mesher

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Philips to Competitors

Grundium Logo
Grundium

Grundium develops a smart and portable scanning microscope for medical and research specialists. The company was founded in 2015 and is based in Tampere, Finland.

Aidoc Logo
Aidoc

Aidoc operates as a healthcare technology company. It offers a Care Coordination platform that provides medical images to detect life-threatening conditions such as intracranial hemorrhage, brain aneurysm, pulmonary embolism, and more. Aidoc was founded in 2016 and is based in New York, New York.

Sectra Logo
Sectra

Sectra (STO: SECTB) develops and sells IT systems and services for radiology and other image-intensive departments, orthopaedics and rheumatology.

P
Paige

Paige delivers artificial intelligence (AI) integrated digital diagnostics solutions and biomarkers for pathologists, oncologists, and the cancer diagnostics research and development community. It works with biopharma companies to create custom diagnostic solutions and drug development technologies to improve patient care. The company was founded in 2017 and is based in New York, New York.

Huma Logo
Huma

Huma offers an intelligent software solution to combine predictive algorithms, artificial intelligence (AI), digital biomarkers, and data from patients. It remotely monitors patient indicators and assists researchers and pharmaceutical companies in conducting decentralized clinical trials. It combines digital biomarkers and predictive algorithms to offer a blend of medical expertise with several leading healthcare institutes. It was formerly known as Medopad. The company was founded in 2011 and is based in London, United Kingdom.

MediSafe Logo
MediSafe

MediSafe develops a medication engagement platform. The platform helps people integrate healthier behavior into their daily lives with a cloud-synced mobile medication management system. It offers solutions, data insights, research, webinars, case studies, and more. The company is founded in 2012 and is based in Needham, Massachusetts.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.